Rapidly changing evidence sparks need for ‘living’ guidelines The RACGP has requested Federal Government support to establish clinical resources that incorporate new information as it comes to hand.
Why the emergence of JN.1 is significant The new COVID variant is an evolutionary ‘step change’ in the pandemic, according to Australian researchers.
How long does immunity last after a COVID infection? Dr Lara Herrero and Wesley Freppel assess the latest evidence, including the impact vaccination and emerging variants can have.
Study links blood protein changes to long COVID Researchers are hopeful that the findings could help improve diagnosis and treatment of a condition it says remains ‘poorly understood’.
New COVID variant ‘taking off like a rocket’ Despite states and territories reporting large case increases, many Australians have not received booster vaccinations to protect against JN.1.
Tighten Paxlovid eligibility: PBAC advice The committee that looks at PBS listings has recommended the first-line COVID-19 treatment be limited to the highest risk patients aged 50–69 years.
Primary care boost key to better pandemic response: Report The Grattan Institute has set out why it believes improved funding would reduce the higher toll on the most vulnerable communities.
GPs crucial to fighting future pandemics: RACGP The college is calling for recognition of GPs as frontline workers if a pandemic hits, while pleading with leaders to ‘cut us some slack’.
The top general practice stories of 2023 Sixty-day dispensing, red tape and Medicare funding were high on the agenda for GPs this year.
Call for more investment in long COVID treatment Concern over long COVID clinic closures prompts push for more funding to boost care for patients with the condition.